| Accent Group Limited (AX1) ORDINARY FULLY PAID |
Consumer Discretionary |
$388 |
Retirement of Chairman
|
26 May 2025 9:17AM |
$1.905 |
$0.645 |
fallen by
66.14%
|
|
| Mt Malcolm Mines NL (M2M) ORDINARY FULLY PAID |
Materials |
$5 |
RC Drilling Advances at Golden Crown and Dumbarton Prospects
|
26 May 2025 9:16AM |
$0.025 |
$0.010 |
fallen by
60%
|
|
M2M - Price-sensitive ASX Announcement
Full Release
Key Points
- Mt Malcolm Mines NL conducted RC drilling at the Golden Crown and Dumbarton prospects.
- Drilling targeted the extension and definition of known high-grade gold intersections.
- Early results show promising mineralization extensions at the Golden Crown prospect.
- Both prospects display potential for further resource enhancement and future drilling.
- Exploration efforts are guided by ongoing geological analysis and prospectivity mapping.
- The company intends to continue drilling to increase confidence in resource estimates.
- The announcement reinforces the strategic value of Golden Crown and Dumbarton in the company's exploration portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$162 |
Viva Leisure Acquires 33% Stake in Gorilla X Labs
|
26 May 2025 9:15AM |
$1.340 |
$1.595 |
risen by
19.03%
|
|
VVA - Price-sensitive ASX Announcement
Full Release
Key Points
- Viva Leisure Limited acquires a 33% equity stake in Gorilla X Labs.
- Gorilla X Labs specializes in fitness technology innovation.
- The transaction supports Viva Leisure’s digital strategy.
- The investment aims to enhance member engagement through advanced technology.
- Viva Leisure intends to explore additional technology-driven growth opportunities.
- The acquisition is expected to strengthen Viva Leisure’s position in the fitness industry.
- The announcement was made on 6 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Duxton Water Limited (D2O) ORDINARY FULLY PAID |
Utilities |
- |
Update - Notification of buy-back - D2O
|
26 May 2025 9:14AM |
$1.560 |
$1.530 |
fallen by
1.92%
|
|
| Western Gold Resources Limited (WGR) ORDINARY FULLY PAID |
Materials |
$46 |
Trading Halt
|
26 May 2025 9:13AM |
$0.063 |
$0.155 |
risen by
146.03%
|
|
WGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Western Gold Resources Limited (WGR) has requested a trading halt.
- The trading halt is in connection with a proposed capital raising.
- The halt commenced on 11 June 2024.
- Trading will resume at the earlier of an announcement or the start of trading on 13 June 2024.
- The halt is to ensure the market is fully informed and to comply with continuous disclosure obligations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,370 |
Weekly Estimated NTA as at 23 May 2025
|
26 May 2025 9:13AM |
$7.200 |
$6.700 |
fallen by
6.94%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,263 |
Approval to Escalate Dosing in Kidney Disease Trial
|
26 May 2025 9:13AM |
$1.200 |
$1.285 |
risen by
7.08%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics Limited received approval to escalate dosing in its ADPKD clinical trial.
- The decision follows a successful safety review of the lower dose, with no dose-limiting toxicities observed.
- The next stage involves a higher dose in the single ascending dose phase.
- The study aims to evaluate safety, tolerability, pharmacokinetics, and exploratory biomarkers.
- PYC’s investigational drug targets rare kidney diseases, focusing on a genetically validated approach.
- The clinical trial is progressing on schedule, demonstrating PYC’s commitment to RNA therapy innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| New World Resources Limited (NWC) ORDINARY FULLY PAID |
Materials |
- |
Antler Project Designated as FAST-41 Transparency Project
|
26 May 2025 9:12AM |
$0.047 |
$0.067 |
risen by
42.55%
|
|
NWC - Price-sensitive ASX Announcement
Full Release
Key Points
- New World Resources Limited's Antler Copper Project has been designated a FAST-41 Covered Project by the Federal Permitting Improvement Steering Council (FPISC)
- FAST-41 designation offers transparency, coordination, and expedited permitting for large infrastructure projects in the United States
- The Antler Project is located in northern Arizona and contains significant resources of copper, zinc, lead, gold, and silver
- The project is positioned to support U.S. supply chains for clean energy and renewable technologies by providing critical minerals
- FAST-41 status provides a coordinated permitting timetable and a single point of accountability within U.S. federal agencies
- The designation is expected to facilitate efficient, transparent, and timely review and development of the Antler Project
- NWC emphasizes the strategic value of being a domestic supplier of copper and other critical minerals in the U.S.
- Environmental review and consultation processes will be comprehensive under the FAST-41 framework
- The announcement reflects NWC's progress towards advancing the Antler Project towards development and production
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$602 |
Weekly Estimated NTA as at 23 May 2025
|
26 May 2025 9:12AM |
$3.190 |
$2.690 |
fallen by
15.67%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,536 |
Update - Notification of buy-back - NEU
|
26 May 2025 9:11AM |
$12.870 |
$12.140 |
fallen by
5.67%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$380 |
Update - Notification of buy-back - ACL
|
26 May 2025 9:11AM |
$2.950 |
$2.020 |
fallen by
31.53%
|
|
| Noviqtech Limited (NVQ) ORDINARY FULLY PAID |
Information Technology |
$9 |
NVQ & Hedera Foundation Extend Strategic Collaboration
|
26 May 2025 9:10AM |
$0.026 |
$0.024 |
fallen by
7.69%
|
|
NVQ - Price-sensitive ASX Announcement
Full Release
Key Points
- NVQ and the Hedera Foundation have extended their strategic collaboration.
- The partnership focuses on advancing distributed ledger technology and applications.
- NVQ will utilize Hedera's decentralized public network for digital asset management and tokenization.
- The collaboration aims to foster innovation and transparency in blockchain solutions.
- Efforts are directed at accelerating DLT adoption across multiple industries.
- Both parties commit to developing secure, scalable, and efficient blockchain infrastructures for enterprise use.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Redstone Resources Limited (RDS) ORDINARY FULLY PAID |
Materials |
$4 |
Trading Halt
|
26 May 2025 9:09AM |
$0.007 |
$0.003 |
fallen by
57.14%
|
|
RDS - Price-sensitive ASX Announcement
Full Release
Key Points
- Redstone Resources Limited requests a trading halt effective 6 June 2024.
- The trading halt is pending the release of an announcement about a capital raising.
- Trading halt will end upon the announcement or at the start of trading on 10 June 2024.
- Purpose of the halt is to ensure the market is fully informed.
- Company states it is unaware of any reason for the trading halt not to be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,403 |
Net Tangible Asset Backing - 23 May 2025
|
26 May 2025 9:08AM |
$2.520 |
$2.920 |
risen by
15.87%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$30,408 |
Notification of cessation of securities - BXB
|
26 May 2025 9:08AM |
$22.060 |
$22.530 |
risen by
2.13%
|
|
| Ryder Capital Limited (RYD) ORDINARY FULLY PAID |
Financials |
$154 |
Update - Notification of buy-back - RYD
|
26 May 2025 9:08AM |
$1.300 |
$1.910 |
risen by
46.92%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$720 |
Weekly Estimate NTA for 23.05.2025
|
26 May 2025 9:08AM |
$2.820 |
$3.440 |
risen by
21.99%
|
|
| Select Harvests Limited (SHV) ORDINARY FULLY PAID |
Consumer Staple |
$534 |
Select Harvests 1H FY2025 Results Webcast
|
26 May 2025 9:07AM |
$4.490 |
$3.760 |
fallen by
16.26%
|
|
| Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$962 |
Update - Notification of buy-back - LFSPA
|
26 May 2025 9:07AM |
$1.130 |
$0.925 |
fallen by
18.14%
|
|
| Podium Minerals Limited (POD) ORDINARY FULLY PAID |
Materials |
$50 |
Trading Halt
|
26 May 2025 9:06AM |
$0.037 |
$0.051 |
risen by
37.84%
|
|
POD - Price-sensitive ASX Announcement
Full Release
Key Points
- Podium Minerals Limited requested a trading halt effective from 6 June 2024.
- The trading halt relates to a pending capital raising announcement.
- The halt will remain until the earlier of trading resumption on 10 June 2024 or the capital raising announcement.
- The request was made to ensure a fair and informed market.
- Podium Minerals Limited confirmed there is no reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alma Metals Limited (ALM) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$29 |
Cleansing Notice
|
26 May 2025 9:06AM |
$0.004 |
$0.013 |
risen by
225%
|
|
| Alma Metals Limited (ALM) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$29 |
Pro-Rata Non-Renounceable Rights Offer
|
26 May 2025 9:06AM |
$0.004 |
$0.013 |
risen by
225%
|
|
ALM - Price-sensitive ASX Announcement
Full Release
Key Points
- Alma Metals Limited is conducting a pro-rata non-renounceable rights offer to raise funds.
- The rights offer is available to eligible shareholders to subscribe for new shares at a fixed price.
- Funds raised will primarily be used for exploration and drilling at the Briggs, Mannersley, and Fig Tree Hill Copper Project.
- The rights offer includes provisions for the allocation of shortfall shares.
- Key risk factors are identified, including exploration risk, commodity price fluctuation, and dilution of existing shareholdings.
- The offer is not underwritten, but arrangements for shortfall placement are established.
- Details are provided on the effect of the offer on Alma Metals’ capital structure and shareholding.
- Comprehensive instructions guide shareholders on how to participate in the offer.
- The document outlines expected key dates for the rights issue process.
- Information is provided on company operations, management, financials, and corporate governance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jade Gas Holdings Limited (JGH) ORDINARY FULLY PAID |
Energy |
$94 |
Jade Prepares to Commence Gas Production
|
26 May 2025 9:05AM |
$0.028 |
$0.049 |
risen by
75%
|
|
JGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Jade Gas Holdings Limited is preparing to commence gas production at the Red Lake Project in Mongolia.
- All necessary regulatory approvals have been secured for production activities.
- Technical preparations such as well workovers and installation of surface facilities are complete.
- Mobilization of equipment and personnel to the site is underway.
- Initial gas production will begin from the SL-02 well.
- Produced gas will be utilized for pilot power generation and ongoing field-testing.
- Jade is transitioning from exploration to production phase.
- Plans are in place to expand production from additional wells in the near term.
- Company is progressing with resource appraisal and development activities.
- Efforts are being made to engage with the market for long-term commercial gas sales.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$10 |
Preliminary Final Results Presentation
|
26 May 2025 9:05AM |
$0.026 |
$0.014 |
fallen by
46.15%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Truscreen Group Limited saw increased device placements and test volumes, particularly in China.
- Revenue grew year-over-year, but the company reported continued operating losses due to ongoing investments.
- The company focused on expanding clinical evidence to support its cervical cancer screening technology.
- Key markets include China, Mexico, Vietnam, and other emerging economies.
- Product development initiatives and regulatory approvals are central to future growth strategies.
- Truscreen pursued partnerships to drive commercial adoption and market expansion.
- The company is committed to enhancing its products, developing new software, and integrating additional services.
- The board and management are optimistic about future growth opportunities.
- Financial results reflect increased operating expenditures aligned with strategic growth plans.
- Efforts continue to raise awareness and adoption among healthcare providers and governments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$10 |
Preliminary Final Report
|
26 May 2025 9:05AM |
$0.026 |
$0.014 |
fallen by
46.15%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- TRU focused on commercialising its TruScreen cervical cancer screening technology.
- The company expanded its sales and distribution network in international markets, especially in China and Eastern Europe.
- Annual revenue increased compared to the previous year, with growth attributed mainly to new distributors and increased device placements.
- Investment in research and development continued, with ongoing clinical studies aimed at improving product efficacy and regulatory approvals.
- Operational expenses rose due to expansion activities and increased investment in sales infrastructure.
- The company faced challenges including supply chain disruptions and regulatory delays in some markets.
- Management outlined future strategies involving product enhancements, continued market expansion, and development of new partnerships.
- Risk disclosures include uncertainties related to regulatory approvals, competitive pressures, and reliance on distributor performance.
- Corporate governance structures and board responsibilities are detailed in accordance with NZX listing rules.
- Detailed financial statements and accompanying notes are included covering profit and loss, balance sheet, and cash flow for the reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
